Q13554 (KCC2B_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
April 3, 2013.
Version 136.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Calcium/calmodulin-dependent protein kinase type II subunit beta Short name=CaM kinase II subunit beta Short name=CaMK-II subunit beta EC=2.7.11.17 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 666 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Calcium/calmodulin-dependent protein kinase that functions autonomously after Ca2+/calmodulin-binding and autophosphorylation, and is involved in dendritic spine and synapse formation, neuronal plasticity and regulation of sarcoplasmic reticulum Ca2+ transport in skeletal muscle. In neurons, plays an essential structural role in the reorganization of the actin cytoskeleton during plasticity by binding and bundling actin filaments in a kinase-independent manner. This structural function is required for correct targeting of CaMK2A, which acts downstream of NMDAR to promote dendritic spine and synapse formation and maintain synaptic plasticity which enables long-term potentiation (LTP) and hippocampus-dependent learning. In developing hippocampal neurons, promotes arborization of the dendritic tree and in mature neurons, promotes dendritic remodeling. Participates in the modulation of skeletal muscle function in response to exercise. In slow-twitch muscles, is involved in regulation of sarcoplasmic reticulum (SR) Ca2+ transport and in fast-twitch muscle participates in the control of Ca2+ release from the SR through phosphorylation of triadin, a ryanodine receptor-coupling factor, and phospholamban (PLN/PLB), an endogenous inhibitor of SERCA2A/ATP2A2. Ref.11 |
| Catalytic activity | ATP + a protein = ADP + a phosphoprotein. |
| Enzyme regulation | Activated by Ca2+/calmodulin. Binding of calmodulin results in conformational change that relieves intrasteric autoinhibition and allows autophosphorylation of Thr-287 which turns the kinase in a constitutively active form and confers to the kinase a Ca2+-independent activity. Ref.9 |
| Subunit structure | CAMK2 is composed of 4 different chains: alpha (CAMK2A), beta (CAMK2B), gamma (CAMK2G), and delta (CAMK2D). The different isoforms assemble into homo- or heteromultimeric holoenzymes composed of 12 subunits with two hexameric rings stacked one on top of the other. Interacts with SYNGAP1 and CAMK2N2 By similarity. Interacts with MPDZ. Ref.9 Ref.10 |
| Subcellular location | Cytoplasm › cytoskeleton. Cytoplasm › cytoskeleton › centrosome By similarity. Sarcoplasmic reticulum membrane; Peripheral membrane protein; Cytoplasmic side. Note: In slow-twitch muscle, evenly distributed between longitudinal SR and junctional SR. Ref.13 |
| Tissue specificity | Widely expressed. Expressed in adult and fetal brain. Expression is slightly lower in fetal brain. Expressed in skeletal muscle. Ref.11 |
| Induction | Activity is induced in skeletal muscle during exercise. Ref.9 Ref.11 |
| Domain | The CAMK2 protein kinases contain a unique C-terminal subunit association domain responsible for oligomerization. |
| Post-translational modification | Autophosphorylation of Thr-287 following activation by Ca2+/calmodulin. Phosphorylation of Thr-287 locks the kinase into an activated state. |
| Sequence similarities | Belongs to the protein kinase superfamily. CAMK Ser/Thr protein kinase family. CaMK subfamily. Contains 1 protein kinase domain. |
| Sequence caution | The sequence AAC99802.1 differs from that shown. Reason: Frameshift at positions 426, 433, 511 and 516. |
Ontologies
Alternative products
| This entry describes 8 isoforms produced by alternative splicing. [Align] [Select] Note: The variable region of the CAMK2B protein is encoded by at least 7 exons (V1 to V7). Alternative splicing within this region gives rise to CAMK2B isoforms. | ||||||
| Isoform 4 (identifier: Q13554-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 1 (identifier: Q13554-2) Also known as: Beta; The sequence of this isoform differs from the canonical sequence as follows: 410-533: Missing. | ||||||
| Isoform 2 (identifier: Q13554-3) Also known as: Beta1; Beta'E; The sequence of this isoform differs from the canonical sequence as follows: 316-316: V → A 317-340: Missing. 379-393: Missing. 410-533: Missing. | ||||||
| Isoform 3 (identifier: Q13554-4) Also known as: Beta2; The sequence of this isoform differs from the canonical sequence as follows: 316-316: V → A 317-340: Missing. 354-392: Missing. 410-533: Missing. | ||||||
| Isoform 5 (identifier: Q13554-5) Also known as: Beta4; BetaE; The sequence of this isoform differs from the canonical sequence as follows: 316-316: V → A 317-340: Missing. 410-533: Missing. | ||||||
| Isoform 6 (identifier: Q13554-6) Also known as: Beta6; The sequence of this isoform differs from the canonical sequence as follows: 354-377: Missing. 410-533: Missing. 559-584: Missing. | ||||||
| Isoform 7 (identifier: Q13554-7) Also known as: Beta7; The sequence of this isoform differs from the canonical sequence as follows: 316-316: V → A 317-533: Missing. | ||||||
| Isoform 8 (identifier: Q13554-8) The sequence of this isoform differs from the canonical sequence as follows: 316-340: Missing. 410-533: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 666 | 666 | Calcium/calmodulin-dependent protein kinase type II subunit beta | PRO_0000086096 | |||||||||||||||||||||||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 14 – 272 | 259 | Protein kinase | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Nucleotide binding | 20 – 28 | 9 | ATP By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Region | 283 – 292 | 10 | Autoinhibitory domain By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Region | 291 – 301 | 11 | Calmodulin-binding | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Sites | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Active site | 136 | 1 | Proton acceptor By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Binding site | 43 | 1 | ATP By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 17 | 1 | Phosphotyrosine By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 287 | 1 | Phosphothreonine; by autocatalysis Ref.11 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 306 | 1 | Phosphothreonine; by autocatalysis By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 307 | 1 | Phosphothreonine; by autocatalysis By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 315 | 1 | Phosphoserine By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 367 | 1 | Phosphoserine By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 397 | 1 | Phosphoserine By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 316 – 340 | 25 | Missing in isoform 8. | VSP_041219 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 316 | 1 | V → A in isoform 2, isoform 3, isoform 5 and isoform 7. | VSP_004770 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 317 – 533 | 217 | Missing in isoform 7. | VSP_004772 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 317 – 340 | 24 | Missing in isoform 2, isoform 3 and isoform 5. | VSP_004771 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 354 – 392 | 39 | Missing in isoform 3. | VSP_004774 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 354 – 377 | 24 | Missing in isoform 6. | VSP_004773 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 379 – 393 | 15 | Missing in isoform 2. | VSP_004775 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 410 – 533 | 124 | Missing in isoform 1, isoform 2, isoform 3, isoform 5, isoform 6 and isoform 8. | VSP_004776 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 559 – 584 | 26 | Missing in isoform 6. | VSP_004777 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 489 | 1 | P → L in a colorectal adenocarcinoma sample; somatic mutation. Ref.19 | VAR_045581 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 510 | 1 | E → K. Ref.19 | VAR_045582 | |||||||||||||||||||||||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 68 | 1 | L → V in AAD03744. Ref.3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 68 | 1 | L → V in AAD03743. Ref.3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 535 | 1 | K → N in AAB16863. Ref.8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Isoform 2: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 316 | 1 | A → V in AAD42036. Ref.1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 14 – 19 | 6 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 27 – 33 | 7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 34 – 36 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 39 – 46 | 8 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 52 – 67 | 16 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 76 – 81 | 6 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 83 – 91 | 9 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 95 – 97 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 98 – 102 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 110 – 129 | 20 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 139 – 141 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 142 – 145 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 153 – 155 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 178 – 180 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 183 – 186 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 194 – 209 | 16 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 219 – 228 | 10 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 235 – 238 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 239 – 241 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 243 – 252 | 10 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 257 – 259 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 263 – 266 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 270 – 273 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 275 – 278 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 285 – 298 | 14 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Identification of alternative splicing variants of the beta subunit of human Ca(2+)/calmodulin-dependent protein kinase II with different activities." Wang P., Wu Y., Zhou T.H., Sun Y., Pei G. FEBS Lett. 475:107-110(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 5; 6 AND 7). Tissue: Brain. |
| [2] | Leddy J.J., Salih M., Tuana B.S. Submitted (MAR-1995) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4). Tissue: Skeletal muscle. |
| [3] | "Molecular cloning and sequencing of human calcium/calmodulin dependent protein kinase II beta subunit." Li G.Y., Cooper N.G.F. Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 5). Tissue: Brain. |
| [4] | "Cloning and quantitative determination of the human Ca2+/calmodulin-dependent protein kinase II (CaMK II) isoforms in human beta cells." Rochlitz H., Voigt A., Lankat-Buttgereit B., Goeke B., Heimberg H., Nauck M.A., Schiemann U., Schatz H., Pfeiffer A.F. Diabetologia 43:465-473(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 3 AND 5). Tissue: Insulinoma. |
| [5] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2). Tissue: Testis and Thalamus. |
| [6] | "Human chromosome 7: DNA sequence and biology." Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K., Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R., Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A., Kanematsu E., Gentles S. Tsui L.-C.Science 300:767-772(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [7] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). Tissue: Lung. |
| [8] | "Identification of novel human tumor cell-specific CaMK-II variants." Tombes R.M., Krystal G.W. Biochim. Biophys. Acta 1355:281-292(1997) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 302-605 (ISOFORM 2). |
| [9] | "Comparative analyses of the three-dimensional structures and enzymatic properties of alpha, beta, gamma and delta isoforms of Ca2+-calmodulin-dependent protein kinase II." Gaertner T.R., Kolodziej S.J., Wang D., Kobayashi R., Koomen J.M., Stoops J.K., Waxham M.N. J. Biol. Chem. 279:12484-12494(2004) [PubMed] [Europe PMC] [Abstract] Cited for: ENZYME REGULATION, SUBUNIT, AUTOPHOSPHORYLATION. |
| [10] | "SynGAP-MUPP1-CaMKII synaptic complexes regulate p38 MAP kinase activity and NMDA receptor-dependent synaptic AMPA receptor potentiation." Krapivinsky G., Medina I., Krapivinsky L., Gapon S., Clapham D.E. Neuron 43:563-574(2004) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH MPDZ. |
| [11] | "Ca2+-calmodulin-dependent protein kinase expression and signalling in skeletal muscle during exercise." Rose A.J., Kiens B., Richter E.A. J. Physiol. (Lond.) 574:889-903(2006) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION IN SKELETAL MUSCLE, PHOSPHORYLATION AT THR-287, FUNCTION IN PHOSPHORYLATION OF PLN, TISSUE SPECIFICITY, INDUCTION. |
| [12] | "Large-scale proteomics analysis of the human kinome." Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G., Mann M., Daub H. Mol. Cell. Proteomics 8:1751-1764(2009) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [13] | "Analysis of CaM-kinase signaling in cells." Wayman G.A., Tokumitsu H., Davare M.A., Soderling T.R. Cell Calcium 50:1-8(2011) [PubMed] [Europe PMC] [Abstract] Cited for: SUBCELLULAR LOCATION. |
| [14] | "The role of calcium and calcium/calmodulin-dependent kinases in skeletal muscle plasticity and mitochondrial biogenesis." Chin E.R. Proc. Nutrit. Soc. 63:279-286(2004) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW ON FUNCTION IN SKELETAL MUSCLE. |
| [15] | "The Ca2+-calmodulin dependent protein kinase II system of skeletal muscle sarcoplasmic reticulum." Sacchetto R., Bovo E., Damiani E. Basic Appl. Myol. 15:5-17(2005) Cited for: REVIEW ON FUNCTION IN SKELETAL MUSCLE. |
| [16] | "Calmodulin-kinases: modulators of neuronal development and plasticity." Wayman G.A., Lee Y.S., Tokumitsu H., Silva A.J., Silva A., Soderling T.R. Neuron 59:914-931(2008) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW ON FUNCTION IN NEURONAL PLASTICITY. |
| [17] | "The roles of CaMKII and F-actin in the structural plasticity of dendritic spines: a potential molecular identity of a synaptic tag?" Okamoto K., Bosch M., Hayashi Y. Physiology (Bethesda) 24:357-366(2009) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW ON FUNCTION IN NEURONAL PLASTICITY. |
| [18] | "Crystal structure of human calcium/calmodulin-dependent protein kinase IIb isoform 1 (CAMK2B)." Structural genomics consortium (SGC) Submitted (DEC-2007) to the PDB data bank Cited for: X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 11-303 IN COMPLEX WITH INHIBITOR. |
| [19] | "Patterns of somatic mutation in human cancer genomes." Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G. Stratton M.R.Nature 446:153-158(2007) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS [LARGE SCALE ANALYSIS] LEU-489 AND LYS-510. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AF078803 mRNA. Translation: AAD42035.1. AF081572 mRNA. Translation: AAD42036.1. AF081924 mRNA. Translation: AAD42037.1. AF083419 mRNA. Translation: AAD42038.1. AF140350 mRNA. Translation: AAD42070.1. U23460 mRNA. Translation: AAC99802.1. Frameshift. AF112472 mRNA. Translation: AAD03744.1. AF112471 mRNA. Translation: AAD03743.1. AJ252236 mRNA. Translation: CAB65120.1. AJ252237 mRNA. Translation: CAB65121.1. AJ252238 mRNA. Translation: CAB65122.1. AK290148 mRNA. Translation: BAF82837.1. AK315663 mRNA. Translation: BAG38029.1. CH236960 Genomic DNA. Translation: EAL23756.1. CH236960 Genomic DNA. Translation: EAL23757.1. CH236960 Genomic DNA. Translation: EAL23758.1. CH236960 Genomic DNA. Translation: EAL23759.1. CH236960 Genomic DNA. Translation: EAL23760.1. CH236960 Genomic DNA. Translation: EAL23761.1. CH236960 Genomic DNA. Translation: EAL23762.1. BC019070 mRNA. Translation: AAH19070.1. U50358 mRNA. Translation: AAB16863.1. | ||||||||||||
| IPI | IPI00182944. IPI00183066. IPI00219165. IPI00219166. IPI00221305. IPI00298090. IPI00334271. IPI00377174. | ||||||||||||
| RefSeq | NP_001211.3. NM_001220.4. NP_742075.1. NM_172078.2. NP_742076.1. NM_172079.2. NP_742077.1. NM_172080.2. NP_742078.1. NM_172081.2. NP_742079.1. NM_172082.2. NP_742080.1. NM_172083.2. NP_742081.1. NM_172084.2. | ||||||||||||
| UniGene | Hs.351887. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | Q13554. | ||||||||||||
| SMR | Q13554. Positions 8-662. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| DIP | DIP-39770N. | ||||||||||||
| IntAct | Q13554. 3 interactions. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | Q13554. | ||||||||||||
Polymorphism databases | |||||||||||||
| DMDM | 12643413. | ||||||||||||
Proteomic databases | |||||||||||||
| PaxDb | Q13554. | ||||||||||||
| PRIDE | Q13554. | ||||||||||||
Protocols and materials databases | |||||||||||||
| DNASU | 816. | ||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000258682; ENSP00000258682; ENSG00000058404. ENST00000346990; ENSP00000326518; ENSG00000058404. ENST00000347193; ENSP00000326544; ENSG00000058404. ENST00000350811; ENSP00000326375; ENSG00000058404. ENST00000353625; ENSP00000326427; ENSG00000058404. ENST00000358707; ENSP00000351542; ENSG00000058404. ENST00000395747; ENSP00000379096; ENSG00000058404. ENST00000395749; ENSP00000379098; ENSG00000058404. ENST00000440254; ENSP00000397937; ENSG00000058404. ENST00000457475; ENSP00000390292; ENSG00000058404. | ||||||||||||
| GeneID | 816. | ||||||||||||
| KEGG | hsa:816. | ||||||||||||
| UCSC | uc003tkp.2. human. uc003tkq.2. human. uc003tkr.2. human. uc003tkt.2. human. uc003tku.2. human. uc003tkv.2. human. uc003tkw.2. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 816. | ||||||||||||
| GeneCards | GC07M044225. | ||||||||||||
| HGNC | HGNC:1461. CAMK2B. | ||||||||||||
| HPA | CAB006849. HPA026307. | ||||||||||||
| MIM | 607707. gene. | ||||||||||||
| neXtProt | NX_Q13554. | ||||||||||||
| PharmGKB | PA91. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | COG0515. | ||||||||||||
| HOVERGEN | HBG108055. | ||||||||||||
| InParanoid | Q13554. | ||||||||||||
| KO | K04515. | ||||||||||||
| OMA | VGPPPCL. | ||||||||||||
| PhylomeDB | Q13554. | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| BRENDA | 2.7.11.17. 2681. | ||||||||||||
| Pathway_Interaction_DB | ifngpathway. IFN-gamma pathway. p38_mkk3_6pathway. p38 MAPK signaling pathway. | ||||||||||||
| Reactome | REACT_13685. Neuronal System. REACT_6900. Immune System. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | Q13554. | ||||||||||||
| Bgee | Q13554. | ||||||||||||
| Genevestigator | Q13554. | ||||||||||||
| GermOnline | ENSG00000058404. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR020636. Ca/CaM-dep_Ca-dep_prot_Kinase. IPR013543. Ca/CaM-dep_prot_kinase-assoc. IPR011009. Kinase-like_dom. IPR000719. Prot_kinase_cat_dom. IPR017441. Protein_kinase_ATP_BS. IPR002290. Ser/Thr_dual-sp_kinase_dom. IPR008271. Ser/Thr_kinase_AS. [Graphical view] | ||||||||||||
| PANTHER | PTHR24347. PTHR24347. 1 hit. | ||||||||||||
| Pfam | PF08332. CaMKII_AD. 1 hit. PF00069. Pkinase. 1 hit. [Graphical view] | ||||||||||||
| SMART | SM00220. S_TKc. 1 hit. [Graphical view] | ||||||||||||
| SUPFAM | SSF56112. Kinase_like. 1 hit. | ||||||||||||
| PROSITE | PS00107. PROTEIN_KINASE_ATP. 1 hit. PS50011. PROTEIN_KINASE_DOM. 1 hit. PS00108. PROTEIN_KINASE_ST. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| BindingDB | Q13554. | ||||||||||||
| ChEMBL | CHEMBL4121. | ||||||||||||
| EvolutionaryTrace | Q13554. | ||||||||||||
| GenomeRNAi | 816. | ||||||||||||
| NextBio | 3310. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | KCC2B_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q13554 Secondary accession number(s): A4D2K0 Q9Y6F4 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human and mouse protein kinases Human and mouse protein kinases: classification and index |
| Human chromosome 7 Human chromosome 7: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
